Cromolyn sodium vs placebo
Risk for at least one adverse event per patient · patients with chronic kidney disease (CKD) pruritus
It is very uncertain whether summary of findings table ‐ Cromolyn sodium changes risk for at least one adverse event per patient compared with placebo (very low certainty).
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyRR 1.28 [0.02, 106.52]2 studies · 122 participantsVery low